Diabetes & Endocrinology – Page 5

Oral Glucose Absorption Enhanced in Early Metabolic Dysfunction-Associated Steatotic Liver Disease

By MedXY 04/30/2026

New research reveals accelerated glucose absorption in early MASLD patients, independent of gastric emptying. This metabolic alteration may drive liver disease progression before hepatic insulin resistance develops.

Diabetes & Endocrinology Gastroenterology news

Early MASLD Is Associated With Enhanced Oral Glucose Absorption Independent of Gastric Emptying

By MedXY 04/30/2026

Stable-isotope OGTT data suggest that early MASLD is linked to higher oral glucose absorption, independent of gastric emptying, with preserved hepatic insulin suppression but impaired peripheral glucose clearance.

Diabetes & Endocrinology news Public Health

Microplastics in Human Thyroid: A Potential Trigger for Autoimmune Thyroiditis

By MedXY 04/29/2026

Microplastics detected in thyroid tissues show higher concentrations in autoimmune thyroiditis patients, suggesting a potential environmental link to thyroid autoimmunity.

Diabetes & Endocrinology news Public Health

Ethnicity, Migration, and Mental Health: Independent Risk Factors Persist in Type 2 Diabetes Disparities

By MedXY 04/29/2026

A cohort study reveals persistent ethnic disparities in type 2 diabetes risk, with migration status and mental health conditions as independent contributors, highlighting unmet needs in addressing structural determinants of health inequalities.

Diabetes & Endocrinology news Radiology

AI-Driven Insights into Incidental Thyroid Findings: Prevalence, Clinical Impact, and the Overdiagnosis Dilemma

By MedXY 04/29/2026

A retrospective cohort study using AI to analyze radiology reports reveals high prevalence of incidental thyroid findings, strong association with diagnostic cascades, and potential overdiagnosis of low-risk thyroid cancers.

Diabetes & Endocrinology news Public Health

Intermittent Lifestyle Physical Activity: A Promising Strategy for Type 2 Diabetes Prevention

By MedXY 04/29/2026

Brief, intermittent bouts of moderate- to vigorous-intensity physical activity during daily routines may significantly reduce the risk of type 2 diabetes in adults who do not engage in leisure-time exercise.

Diabetes & Endocrinology news

Real-Time CGM Outperforms SMBG in Glycemic Control for Type 2 Diabetes on Basal Insulin Plus Modern Therapies

By MedXY 04/29/2026

The FreeDM2 trial demonstrates that real-time CGM significantly improves HbA1c levels compared to SMBG in adults with type 2 diabetes on basal insulin and modern therapies, with sustained benefits over 32 weeks.

Cardiology Diabetes & Endocrinology news OB/GYN & Women's Health

Prolonged TSH Suppression in Postmenopausal Thyroid Cancer Patients Linked to Worse Cardiovascular and Quality-of-Life Outcomes

By MedXY 04/28/2026

Study finds long-term TSH suppression in postmenopausal women with thyroid cancer correlates with poorer cardiovascular health, reduced quality of life, and increased osteoporosis risk compared to controls.

Diabetes & Endocrinology news

Exercise Snacks Improve Glycemic Control in Type 2 Diabetes: A Real-World Randomized Crossover Study

By MedXY 04/28/2026

A study demonstrates that short bursts of vigorous bodyweight exercise reduce postprandial hyperglycemia and glycemic variability in individuals with type 2 diabetes, offering a practical intervention for glucose management.

Diabetes & Endocrinology news Pediatrics

Endocrine Profile in Pediatric Bardet-Biedl Syndrome: Insights from a Large Multidisciplinary Cohort

By MedXY 04/28/2026

A retrospective study of 135 pediatric BBS patients reveals high prevalence of obesity (77.6%) and short stature (21.1%), with low rates of hypogonadism, hypothyroidism, and glucose metabolism disorders compared to adult populations.

Clinical Updates Diabetes & Endocrinology news Ophthalmology

Glucagon-Like Peptide-1 Receptor Agonists and Vascular Protection: Mitigating Systemic and Ocular Risks in High-Risk Type 2 Diabetes

By MedXY 04/27/2026

A large-scale cohort study demonstrates that GLP-1 RAs significantly reduce macrovascular and microvascular complications, including proliferative retinopathy and retinal vein occlusion, in patients with pre-existing diabetic retinopathy.

Diabetes & Endocrinology news Ophthalmology

Brolucizumab Outperforms Laser Therapy in Proliferative Diabetic Retinopathy: Insights from the CONDOR Trial

By MedXY 04/27/2026

The CONDOR trial demonstrates brolucizumab's superiority over panretinal photocoagulation in preserving vision and reducing disease progression in proliferative diabetic retinopathy, offering a potential shift in treatment paradigms.

Diabetes & Endocrinology news Radiology

68Ga-Pentixafor PET/CT Predicts Postoperative Outcomes in Primary Aldosteronism Surgery

By MedXY 04/27/2026

68Ga-pentixafor PET/CT parameters correlate with clinical success post-adrenalectomy in primary aldosteronism, offering prognostic insights linked to histopathologic subtypes and CXCR4 expression.

Diabetes & Endocrinology Gastroenterology news

Combination Therapy with GLP-1 Receptor Agonists and SGLT-2 Inhibitors Reduces Liver and Cardiovascular Risks in MASLD and Type 2 Diabetes

By MedXY 04/25/2026

A study reveals that combining GLP-1 receptor agonists with SGLT-2 inhibitors significantly lowers the risk of major adverse liver and cardiovascular outcomes in patients with MASLD and type 2 diabetes compared to monotherapy.

Diabetes & Endocrinology news

uGMI: A More Accurate Alternative to HbA1c for Diabetes Management

By MedXY 04/24/2026

The updated glucose management indicator (uGMI) significantly improves alignment with HbA1c, reducing discordance, particularly in high and low glucose ranges, offering clinicians a more reliable tool for diabetes monitoring.

Diabetes & Endocrinology news Public Health

Long-term Air Pollution Linked to Adverse Body Composition Changes in Older Adults with Metabolic Syndrome

By MedXY 04/24/2026

A study of 1,454 older adults with metabolic syndrome reveals that long-term exposure to air pollutants like black carbon, PM2.5, and NO2 is associated with increased fat mass and decreased lean mass, persisting over three years, particularly in those under 65.

Diabetes & Endocrinology Internal Medicine news

Reevaluating TSH-FT4 Dynamics: New Evidence Challenges Traditional Reference Intervals

By MedXY 04/22/2026

A retrospective study reveals that the TSH-FT4 relationship is segmented, not log-linear, with implications for refining thyroid function test interpretation and reference intervals.

Diabetes & Endocrinology Internal Medicine news

Hospital Delays in Glucose Checks and Insulin Dosing: Do They Impact Patient Care?

By MedXY 04/22/2026

Study reveals significant time gaps between fingerstick glucose tests and insulin administration in hospitals, with nearly 30% of cases potentially receiving incorrect insulin doses due to changing glucose levels during delays.

Diabetes & Endocrinology Gastroenterology news

Somatostatin in the Gut: No Diabetes-Specific Patterns Found

By MedXY 04/22/2026

New study reveals uniform distribution of somatostatin and its receptors throughout the intestinal tract in both healthy individuals and type 2 diabetes patients, challenging previous assumptions about its role in diabetes pathophysiology.

Diabetes & Endocrinology news Public Health

Childhood BMI Trajectories Strongly Predict Adult Metabolic Multimorbidity: A 36-Year Cohort Study Reveals Life-Course Risk Patterns

By MedXY 04/22/2026

A 36-year prospective study demonstrates that cumulative BMI burden from childhood to adulthood significantly elevates risks of metabolic multimorbidity, with distinct life-stage patterns and sex-specific vulnerabilities.